NCT02220855 2022-04-11
A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas
Indiana University
Phase 2 Completed
Clinical Trials
4 trialsNCT01487265 2019-03-06
Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01297491 2016-03-11
BASALT-1
Novartis
Phase 2 Completed
NCT01501604 2015-09-17
BKM120 in Cancers With PIK3CA Activating Mutations
Massachusetts General Hospital
Phase 2 Withdrawn